Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) EPS (Weighted Average and Diluted): 2020-2025

Historic EPS (Weighted Average and Diluted) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$0.18.

  • Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) rose 73.53% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 48.78%. This contributed to the annual value of -$1.05 for FY2024, which is 16.67% down from last year.
  • Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) amounted to -$0.18 in Q3 2025, which was up 33.33% from -$0.27 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) ranged from a high of $0.53 in Q2 2022 and a low of -$0.80 during Q4 2023.
  • In the last 3 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) had a median value of -$0.18 in 2025 and averaged -$0.24.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) surged by 7,647.81% in 2021 and then slumped by 1,260.00% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.43 in 2021, then crashed by 30.23% to $0.30 in 2022, then crashed by 366.67% to -$0.80 in 2023, then surged by 77.50% to -$0.18 in 2024, then spiked by 73.53% to -$0.18 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.18 for Q3 2025, versus -$0.27 for Q2 2025 and -$0.21 for Q1 2025.